Skip to content

Drug interactions

Empagliflozin-metformin + Nateglinide

Severity: Moderate

Empagliflozin-metformin and Nateglinide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Combining an SGLT2 inhibitor with an insulin secretagogue such as nateglinide may increase hypoglycemia risk. The risk is lower than with sulfonylureas because nateglinide acts briefly, but it is still present.

What this interaction means in plain words

Empagliflozin-metformin and Nateglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Empagliflozin-metformin belongs to Endocrine; Nateglinide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Additive glucose lowering from meal-related insulin secretion by nateglinide and urinary glucose excretion by empagliflozin.

What to do

Consider reducing the nateglinide dose when starting empagliflozin and advise the patient to monitor blood glucose and recognize hypoglycemia symptoms.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Empagliflozin-metformin and Nateglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Empagliflozin-metformin with Nateglinide?

MediHelp rates the interaction as moderate. Empagliflozin-metformin and Nateglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Combining an SGLT2 inhibitor with an insulin secretagogue such as nateglinide may increase hypoglycemia risk. The risk is lower than with sulfonylureas because nateglinide acts briefly, but it is still present.

How serious is the interaction between Empagliflozin-metformin and Nateglinide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider reducing the nateglinide dose when starting empagliflozin and advise the patient to monitor blood glucose and recognize hypoglycemia symptoms.

What other medicines interact with Empagliflozin-metformin?

MediHelp also lists interactions of Empagliflozin-metformin with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Empagliflozin-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in